Table 1 Demographic and baseline clinical characteristics among the studied cases
Variables | D Group (n = 55) | C Group (n = 55) | P-value |
|---|---|---|---|
Age; years | 75.8 (5.4) | 75.6 (5.0) | ^0.826 |
Sex; male/female | 22/33 | 25/30 | #0.563 |
Weight; kg | 67.7 (3.8) | 66.8 (3.2) | ^0.217 |
Height; cm | 167.3 (4.3) | 166.4 (4.9) | ^0.316 |
ASA; I, II, III; n | 4/ 38/ 13 | 7/ 33/ 15 | #0.519 |
Ischemic heart disease (IHD); n | 33 | 39 | #0.229 |
Diabetes Mellitus (DM); n | 20 | 21 | #0.844 |
Renal impairment; n | 11 | 10 | #0.808 |
Hypertension (HTN); n | 42 | 45 | #0.482 |
Anti hypertensive medications; n | 42 | 45 | #0.482 |
• Beta-Blockers | 36 | 40 | #0.409 |
• ACE | 29 | 32 | #0.565 |
• ARBs | 7 | 8 | #0.781 |
• CCB | 6 | 5 | #0.751 |
Valvular heart diseases; n | 15 | 12 | #0.506 |
• Aortic stenosis (mild) | 5 | 4 | §0.999 |
• Aortic stenosis (moderate) | 4 | 3 | §0.999 |
• Mitral regurgitation (moderate) | 6 | 5 | #0.751 |
Surgical procedure | |||
• Total hip | 13 | 15 | §0.839 |
• Total Knee | 14 | 12 | |
• Hip hemi-arthroplasty | 17 | 14 | |
• DHS | 11 | 14 | |